U.S. markets closed
  • S&P 500

    4,594.62
    -106.84 (-2.27%)
     
  • Dow 30

    34,899.34
    -905.06 (-2.53%)
     
  • Nasdaq

    15,491.66
    -353.54 (-2.23%)
     
  • Russell 2000

    2,245.94
    -85.52 (-3.67%)
     
  • Crude Oil

    68.17
    -10.22 (-15.00%)
     
  • Gold

    1,792.30
    +8.00 (+0.45%)
     
  • Silver

    23.15
    -0.35 (-1.52%)
     
  • EUR/USD

    1.1306
    +0.0094 (+0.84%)
     
  • 10-Yr Bond

    1.4820
    -0.1630 (-9.91%)
     
  • GBP/USD

    1.3326
    +0.0006 (+0.05%)
     
  • USD/JPY

    113.6830
    -1.6560 (-1.44%)
     
  • BTC-USD

    54,978.04
    +703.85 (+1.30%)
     
  • CMC Crypto 200

    1,365.60
    -89.81 (-6.17%)
     
  • FTSE 100

    7,044.03
    -266.34 (-3.64%)
     
  • Nikkei 225

    28,751.62
    -747.68 (-2.53%)
     

Global Single Cell Genomics Market to 2025 - Featuring 10X Genomics, Bio-Rad and Dolomite Bio Among Others - ResearchAndMarkets.com

·2 min read

The "Single Cell Genomics Markets" report has been added to ResearchAndMarkets.com's offering.

This report, Single Cell Genomics Markets, provides the most current market research into single cell genomics and the companies that participate in this market. As part of its coverage, the report contains the following information:

  • Single Cell Genomics Products on the Market

  • Market for Single Cell Genomics, 2019-2025

  • Consumables Market, 2019-2025

  • Instrument Market, 2019-2025

  • Litigation and IP

  • Profiles of Companies in the Market

  • Participation Matrix (Who Participates in Single Cell Genomics and Other Genomics Areas)

  • Recent Product Introductions

The study of individual cells has long been an important part of biological research. Historically this has been a very manual process; some automated technologies are available. The need for microscopy and other traditional methods has remained, as new methods have also arrived, all of which have been gradually improved. The ability to amplify DNA or RNA from an individual cell was a key development.

As a result of continuous technological advances in the last 15 years, the use of NGS has constantly gained more acceptance in broad areas of biological research. At the same time, a range of new products has been introduced to allow the isolation and preparation of large numbers of individual cells in parallel. Along with other technological innovations, these have resulted in new capabilities to routinely study large numbers of genes in tens or hundreds of thousands of individual cells.

Companies Profiled include:

  • 10X Genomics

  • Bio-Rad

  • Dolomite Bio

  • Fluidigm

  • Illumina

  • Mission Bio

  • Qiagen

  • Takara Bio

Key Topics Covered:

CHAPTER ONE: EXECUTIVE SUMMARY

  • OVERVIEW

  • PRODUCTS ON THE MARKET

  • SCOPE AND METHODOLOGY

CHAPTER TWO: INTRODUCTION

  • INTRODUCTION

  • APPLICATIONS

    • Infectious Disease

    • Understanding Cancer with miRNAs

    • Atherosclerosis Research

    • Neurological

  • MARKET TRENDS

    • Increasing Numbers of Cells Analyzed

    • Significant Interest in Multi-omics

    • Spatial Transcriptomics, In Situ Techniques Gaining Traction

    • Data Analysis, Data Volumes, High Dimensionality Challenging

    • Convergence of Technological Advances

    • Litigation With Most Major Companies

CHAPTER THREE: MARKET ANALYSIS

  • MARKET ANALYSIS

  • REVENUES FORECAST

  • COMPETITIVE ANALYSIS

  • PRODUCTS

    • New Products

For more information about this report visit https://www.researchandmarkets.com/r/e4v2bk

View source version on businesswire.com: https://www.businesswire.com/news/home/20210215005253/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900